Merck

U.S. stocks fluctuated after equity benchmarks climbed to records last week as Family Dollar Stores Inc. rallied while Merck & Co. slipped amid deals activity.
Merck & Co., the second-biggest U.S. drugmaker, agreed to buy Idenix Pharmaceuticals Inc. for about $3.85 billion to expand its experimental pipeline for hepatitis C treatments.